Chokshi A B, Friedman H S, Malach M, Vasavada B C, Bleicher S J
JAMA. 1981 Aug 14;246(7):754-7.
Because of a sharp increase in the number of permanent pacemakers inserted at The Brooklyn Hospital between 1972 and 1976, a peer-review committee was established to monitor subsequent pacemaker implantation. Total initial implants declined from 48 to 22 per year in the two years that followed. The number of implantations for sinoatrial bradycardias declined from 50 to 27 and the number of implantations for intraventricular conduction defects declined from 32 to five in the two years after peer review, compared with the two years before. There was no change in the number of pacemakers implanted for complete or advanced heart block. Almost 10% of patients who received a pacemaker between 1972 and 1976 had other conditions that might have accounted for the events that precipitated the decision to implant a pacemaker. The symptoms for which the pacemaker was implanted persisted in 19% of patients, despite a normally functioning pacemaker system. Patients receiving a permanent pacemaker before peer review had a 17% one-year and a 43% three-year mortality. When a more critical patient selection process was instituted, a smaller percentage remained symptomatic (9% vs 19%) and three-year survival rate was improved (86% vs 57%). From 1977 through 1978, when permanent pacemaker implantations declined, the number of hospital, medical service, and coronary care unit admissions increased. It is concluded that peer review can have substantial impact on permanent pacemaker implantations.
由于1972年至1976年间布鲁克林医院植入的永久性起搏器数量急剧增加,因此成立了一个同行评审委员会来监测随后的起搏器植入情况。在随后的两年中,每年的初始植入总数从48例下降到22例。与同行评审前的两年相比,同行评审后的两年中,窦房结心动过缓的植入数量从50例下降到27例,室内传导缺陷的植入数量从32例下降到5例。完全性或晚期心脏传导阻滞植入起搏器的数量没有变化。1972年至1976年间接受起搏器治疗的患者中,近10%患有其他疾病,这些疾病可能是促使决定植入起搏器的原因。尽管起搏器系统功能正常,但仍有19%的患者植入起搏器的症状持续存在。同行评审前接受永久性起搏器治疗的患者一年死亡率为17%,三年死亡率为43%。当采用更严格的患者选择程序时,仍有症状的患者比例降低(9%对19%),三年生存率提高(86%对57%)。从1977年到1978年,永久性起搏器植入数量下降时,医院、医疗服务和冠心病监护病房的入院人数增加。结论是同行评审对永久性起搏器植入可能有重大影响。